Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

698

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

February 14, 2023

Conditions
Non Small Cell Lung CancerLung Cancer
Interventions
DRUG

Vandetanib

oral once daily tablet

DRUG

Pemetrexed

intravenous infusion

Trial Locations (110)

Unknown

Research Site, Casa Grande

Research Site, Chandler

Research Site, Farmington

Research Site, Stamford

Research Site, Washington D.C.

Research Site, Orlando

Research Site, Gainesville

Research Site, Skokie

Research Site, Sioux City

Research Site, Mount Sterling

Research Site, Portland

Research Site, Baltimore

Research Site, Rockville

Research Site, Boston

Research Site, St Louis

Research Site, Mineola

Research Site, Rochester

Research Site, Winston-Salem

Research Site, Cincinnati

Research Site, Middletown

Research Site, Hilton Head Island

Research Site, Austin

Research Site, Salt Lake City

Research Site, Avellaneda

Research Site, Buenos Aires

Research Site, Ciudad de Buenos Aires

Research Site, Córdoba

Research Site, La Plata

Research Site, Ramos Mejía

Research Site, Salta

Research Site, Santa Fe

Research Site, Chermside

Research Site, Fitzroy

Research Site, Footscray

Research Site, Heidelberg

Research Site, Randwick

Research Site, St Leonards

Research Site, Wodonga

Research Site, Brussels (Woluwé-St-Lambert)

Research Site, Leuven

Research Site, Liège

Research Site, Bogotá

Research Site, Medellín

Research Site, Pereira

Research Site, Valledupar

Research Site, Avignon

Research Site, Lyon

Research Site, Paris

Research Site, Pontoise

Research Site, Strasbourg

Research Site, Cologne

Research Site, Hanover

Research Site, Karlsruhe

Research Site, Kassel

Research Site, Leipzig

Research Site, N. Faliro

Research Site, Pátrai

Research Site, Thessaloniki

Research Site, Hong Kong

Research Site, Ahmedabad

Research Site, Vellore

Research Site, Beer-Sheeva

Research Site, Haifa

Research Site, Jerusalem

Research Site, Kfar Saba

Research Site, Petah Tikva

Research Site, Safed

Research Site, Tel Litwinsky

Research Site, Ẕerifin

Research Site, Genova

Research Site, Milan

Research Site, Orbassano

Research Site, Roma

Research Site, S.Andrea Delle Fratte

Research Site, Aguascalientes

Research Site, México

Research Site, Puebla City

Research Site, Cebu City

Research Site, Manila

Research Site, Pasay

Research Site, Quezon City

Research Site, Lisbon

Research Site, Santa Maria da Feira

Research Site, Setúbal

Research Site, Cape Town

Research Site, Durban

Research Site, Johannesburg

Research Site, Port Elizabeth

Research Site, Pretoria

Research Site, A Coruña

Research Site, Lugo

Research Site, Majadahonda

Research Site, Mataró(Barcelona)

Research Site, Málaga

Research Site, Ourense

Research Site, Santiago de Compostela(A Coru

Research Site, Vigo(Pontevedra)

Research Site, Lund

Research Site, Sundsvall

Research Site, Umeå

Research Site, Uppsala

Research Site, Västerås

Research Site, Taipei

Research Site, Birmingham

Research Site, Edinburgh

Research Site, Leeds

Research Site, Manchester

Research Site, Wolverhampton

Research Site, Caracas

Research Site, Valencia

All Listed Sponsors
lead

Genzyme, a Sanofi Company

INDUSTRY

NCT00418886 - Efficacy Study Comparing ZD6474 in Combination With Pemetrexed and Pemetrexed Alone in 2nd Line NSCLC Patients | Biotech Hunter | Biotech Hunter